Cardiovascular disease is the leading cause of death in both men and women in the United States, and yet many of the risk factors for developing cardiovascular disease can be avoided or reduced. Obesity, insulin resistance and type 2 diabetes are significant contributors to increased cardiovascular disease risk.
With the current pandemic of COVID-19, cardiometabolic health is emerging as a major risk factor for poor outcomes to COVID-19 infection. Testing and modifying cardiometabolic risk factors with appropriate treatment can help protect the cardiovascular system from attack.
Cardiometabolic risk includes disorders related to obesity and insulin resistance, which can lead to type 2 diabetes and/or heart disease. Risk factors usually appear in a cluster; when one risk factor is present, you should check for others too. According to the American Diabetes Association, diabetic people with higher blood pressure and cholesterol are more likely to be obese. Most of these patients are at risk of developing heart disease due to obesity and related metabolic problems.
- Increased fasting insulin*
- Increased triglycerides*
- Increased C-reactive protein*
- Increased hemoglobin A1c (HbA1c)*
- Decreased HDL cholesterol*
- Increased LDL cholesterol*
- Increased VLDL cholesterol*
- Increased waist circumference
- Increased blood pressure
*Tested in ZRTs CardioMetabolic Profile in dried blood spot
Individuals with one or more of the above risk factors, even if they are not diabetic, have a greater chance of developing other problems. Testing to confirm cardiometabolic risk factors can help assess the extent of overall health risks due to serious and/or under-diagnosed conditions. Proper management of cardiometabolic risk factors can support the overall wellness picture and provide effective tools for improved lifestyle and longevity.